INNOVATE Corp., through its subsidiaries, provides construction, insurance, life sciences, broadcasting, and other services in the United States, the United Kingdom, and internationally. The company models, details, fabricates, and erects structural steel for commercial and industrial, and infrastructure construction projects, including building and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants. It also fabricates trusses and girders; and fabricates and erects water pipes, water storage tanks, pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. In addition, the company provides equipment for the oil and gas industry. Further, it offers long-term care, life, annuity, and other accident and health coverage; focuses on developing products for early osteoarthritis of the knee, as well as skin lightening technology; and operates over-the-air broadcasting stations and Azteca America, a Spanish-language broadcast network. The company was formerly known as HC2 Holdings, Inc. and changed its name to INNOVATE Corp. in September 2021. INNOVATE Corp. was founded in 1994 and is headquartered in New York, New York.
IPO Year:
Exchange: NYSE
Website: innovatecorp.com
8-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
10-Q - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
DEFA14A - INNOVATE Corp. (0001006837) (Filer)
DEF 14A - INNOVATE Corp. (0001006837) (Filer)
10-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per
Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/
NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE
NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Brian Goldstein to fill a vacancy on the INNOVATE Board of Directors, effective immediately. "The addition of Brian strengthens INNOVATE's Board, bringing tax expertise and a unique perspective that will help guide the Company as we strive to optimize our best-in-class assets across our three segments – Infrastructure, Life Sciences and Spectrum – and drive long-term value for our stakeholders," said Avie Glazer, Chairman of INNOVATE. "Brian has been a valuable member of the Board at DBM Global in our Infrastructure segment, and we are confident his dee
- Appoints Two New Directors - Brian Goldstein and Holly Cindell PHOENIX, Oct. 28, 2021 (GLOBE NEWSWIRE) -- DBM Global Inc. announced today the election of two new Board members – Brian Goldstein and Holly Cindell. Current Directors James R. Roach, Michael R. Hill, Robert V. Leffler, Jr., Kenneth S. Courtis, and Wayne Barr, Jr. will also continue their service on the Board. "The DBMG Board is excited to welcome Brian Goldstein, a former partner with PWC, and Holly Cindell, a construction industry veteran, to the Board. We believe that the experience of Brian and Holly will serve to enhance shareholder value in light of our continued expansion this last year," commented Chairman of th